-Nabil Mubarak, Rabab Gaafar, Samir Shehata, Tarek Hashem,
Dani Abigeres, Hamdy A Azim ,Gamal El-Husseiny, Hamed Al-Husaini
and Zhixin Liu :A randomized, phase 2 study comparing pemetrexed plus best
supportive care versus best supportive care as maintenance therapy after
first-line treatment with pemetrexed and cisplatin for advanced, non-squamous
non-small cell lung cancer BMC Cancer 2012, 12:423
- Huober J, Fasching PA, Barsoum M, Petruzelka L, Wallwiener D,
Thomssen C, Reimer T, Paepke S, Azim HA, Ragosch
V, Kubista E, Baumgärtner AK, Beckmann MW, May C, Nimmrich I, Harbeck N Higher
efficacy of letrozole in combination with trastuzumab compared to letrozole
monotherapy as first-line treatment in patients with HER2-positive,
hormone-receptor-positive metastatic breast cancer - Results of the eLEcTRA trial. Breast.
2012 Feb;21(1):27-33.
- -Nagi S. El Saghir , Nadine El-Asmar , Carla Hajj , Toufic Eid , Sami Khatib , Adda Bounedjar ,Dahish Ajarim , Ali Shamseddine , Fady Geara , Abdelrahman Jazieh , Hamdy A. Azim , Yasser Abdelkader , Joseph Kattan , Omalkhair Abulkha :Survey of utilization of multidisciplinary management tumor boards in Arab countries. The Breast 20 (2011) S70-S74
- Naeemt Kassem Novel mutations of nucleoplasmin (NPM-1) gene in Egyptian patients with Acute myeloid leukemia; a pilot study. et al; Journal of the Egyptian NCI (2011) 23, 73-78.
- Azim HA, Bahr SA, Koura MA, Gad H, Farouk M, Morsy A, Iskander I, Hammad A, Fat'hy M, Attia H, Sadek K. Case Study in Refractory Non-Hodgkin's Lymphoma: Successful Treatment with Plerixafor. Case Rep Oncol. 2011 Sep;4(3):467-9.
|